• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CAMP4 Therapeutics Corporation - Common Stock (NQ:CAMP)

    4.560 +0.390 (+9.35%)
    Streaming Delayed Price Updated: 1:50 PM EDT, Aug 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 414,217
    Open 4.200
    Bid (Size) 4.550 (100)
    Ask (Size) 4.580 (2,400)
    Prev. Close 4.170
    Today's Range 4.120 - 4.630
    52wk Range 1.320 - 7.750
    Shares Outstanding 20,161,073
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
    Proceeds of $50.1 million will be used to support the Company’s advancement of CMP-002 for the treatment of SYNGAP1-related disorder 
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
    From CAMP4 Therapeutics
    Via GlobeNewswire

    Performance

    YTD
    -24.0%
    -24.0%
    1 Month
    +1.3%
    +1.3%
    3 Month
    +1.3%
    +1.3%
    6 Month
    +0.4%
    +0.4%
    1 Year
    +235.3%
    +235.3%

    More News

    Read More
    News headline image
    CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer ↗
    Via The Motley Fool
    Topics Initial Public Offering
    News headline image
    CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Appoints Michael MacLean to its Board of Directors
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit ↗
    Via The Motley Fool
    News headline image
    Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit ↗
    Via The Motley Fool
    News headline image
    CAMP4 to Participate in Upcoming Investor Conferences
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out ↗
    Via The Motley Fool
    News headline image
    CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
    From CAMP4 Therapeutics
    Via GlobeNewswire

    Frequently Asked Questions

    Is CAMP4 Therapeutics Corporation - Common Stock publicly traded?
    Yes, CAMP4 Therapeutics Corporation - Common Stock is publicly traded.
    What exchange does CAMP4 Therapeutics Corporation - Common Stock trade on?
    CAMP4 Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CAMP4 Therapeutics Corporation - Common Stock?
    The ticker symbol for CAMP4 Therapeutics Corporation - Common Stock is CAMP on the Nasdaq Stock Market
    What is the current price of CAMP4 Therapeutics Corporation - Common Stock?
    The current price of CAMP4 Therapeutics Corporation - Common Stock is 4.560
    When was CAMP4 Therapeutics Corporation - Common Stock last traded?
    The last trade of CAMP4 Therapeutics Corporation - Common Stock was at 08/12/26 01:50 PM ET
    What is the market capitalization of CAMP4 Therapeutics Corporation - Common Stock?
    The market capitalization of CAMP4 Therapeutics Corporation - Common Stock is 91.93M
    How many shares of CAMP4 Therapeutics Corporation - Common Stock are outstanding?
    CAMP4 Therapeutics Corporation - Common Stock has 92M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.